Details for New Drug Application (NDA): 204300
✉ Email this page to a colleague
NDA 204300 describes VAZCULEP, which is a drug marketed by Exela Pharma and is included in one NDA. Additional details are available on the VAZCULEP profile page.
The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
Summary for 204300
| Tradename: | VAZCULEP |
| Applicant: | Exela Pharma |
| Ingredient: | phenylephrine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 204300
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/ML (10MG/ML) | ||||
| Approval Date: | Jun 27, 2014 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) | ||||
| Approval Date: | Jun 27, 2014 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/10ML (10MG/ML) | ||||
| Approval Date: | Jun 27, 2014 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
